What Factors Make EU Regulators Want to Communicate Drug Safety Issues Related to SGLT2 Inhibitors? An Online Survey Study

Munoz, SR; Postmus, D; de Vries, ST; Gross-Martirosyan, L; Bahri, P; Hillege, H; Mol, PGM

Mol, PGM (通讯作者)，Univ Groningen, Univ Med Ctr Groningen, Dept Clin Pharm & Pharmacol, Groningen, Netherlands.;Mol, PGM (通讯作者)，Dutch Med Evaluat Board, Utrecht, Netherlands.

DRUG SAFETY, 2023; 46 (3): 243

Abstract

IntroductionPrevious studies have found differences in the communication of safety issues among medicines regulatory agencies.ObjectivesTo explore (1)......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索